35 results on '"Jiang, Funeng"'
Search Results
2. Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation
3. Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
4. A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation
5. ShenQi FuZheng Injection ameliorates fatigue-like behavior in mouse models of cancer-related fatigue
6. Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy.
7. Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy
8. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation
9. Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
10. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
11. Figure S5 from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
12. Table S1 from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
13. Data from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
14. Supplementary information from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
15. Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer
16. Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer
17. Aberrant activation of Hedgehog pathway in Nasopharyngeal carcinoma
18. Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients
19. The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation
20. Elevated Levels of Mitochondrion-Associated Autophagy Inhibitor LRPPRC Are Associated With Poor Prognosis in Patients With Prostate Cancer
21. Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
22. Inferences of individual differences in response to tripterysium glycosides across patients with Rheumatoid arthritis using a novel ceRNA regulatory axis
23. KIF4A: A potential biomarker for prediction and prognostic of prostate cancer
24. GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
25. CRISPR/dCas9 (D10A) -Mediated Hb CS Gene Editing and Identification of Genetically Modified Fibroblasts
26. Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
27. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6
28. Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis
29. Association between allergic conditions and risk of prostate cancer: A Prisma-Compliant Systematic Review and Meta-Analysis
30. Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer
31. Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients
32. Aberrant activation of Hedgehog pathway in Nasopharyngeal carcinoma
33. Arginase 2 is a Diagnostic and Prognostic Marker for Prostate Cancer and Is Associated with Metabolism.
34. DCUN1D1 promotes tumour progress in prostate cancer and its effect on DU145 in vitro.
35. [Association of BCL9 expression with prostate cancer clinicopathological features and survival].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.